The STAP-study: The (cost) effectiveness of custom made orthotic insoles in the treatment for plantar fasciopathy in general practice and sports medicine: design of a randomized controlled trial

BMC Musculoskeletal Disorders

Study Protocol

K. J. Gorter¹  N. Rasenberg²  M. van Middelkoop²  P. J. Bindels²  S. M. Bierma-Zeinstra²  P. L. J. van Veldhoven³  A. J. A. Kruijsen-Terpstra⁴  L. Fuit⁵  E. Poppe⁶  M. S. Rathleff⁷ 

[1] Adelbrechtgaarde 5, 7329, Apeldoorn, AT, The Netherlands;Department of General Practice, Erasmus MC, University Medical Centre, Rotterdam, PO Box 2040, 3000, Rotterdam, CA, The Netherlands;Department of Sport Medicine, Medical Centre Haaglanden Antoniushove, Leidschendam, PO Box 411, 2260, Leidschendam, AK, The Netherlands;Dutch Association of Podiatrists, Nederlandse Vereniging van Podotherapeuten, Noordse Bosje 18, 1211, Hilversum, BG, The Netherlands;Podotherapie Fuit, Schaapweg 10c, 2285, Rijswijk, SP, The Netherlands;Podotherapie Voet op Maat, Kortekade 14A, 3062, Rotterdam, GR, The Netherlands;Research Unit for General Practice in Aalborg, Department of ClinicalMedicine, Aalborg University, 9220, Aalborg, DK, Denmark;

关键词: Plantar fasciitis;    Plantar fasciopathy;    Treatment;    Orthotic devices;    Podiatrist;   

DOI  :  10.1186/s12891-016-0889-y

 received in 2015-12-15, accepted in 2016-01-09,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundPlantar fasciopathy is a common cause of foot pain, accounting for 11 to 15 % of all foot symptoms requiring professional care in adults. Although many patients have complete resolution of symptoms within 12 months, many patients wish to reduce this period as much as possible. Orthotic devices are a frequently applied option of treatment in daily practice, despite a lack of evidence on the effectiveness. Therefore, the objective is to study the (cost)-effectiveness of custom made insoles by a podiatrist, compared to placebo insoles and usual care in patients with plantar fasciopathy in general practice and sports medicine clinics.Method/designThis study is a multi-center three-armed participant and assessor-blinded randomized controlled trial with 6-months follow-up. Patients with plantar fasciopathy, with a minimum duration of complaints of 2 weeks and aged between 18 and 65, who visit their general practitioner or sport physician are eligible for inclusion. A total of 185 patients will be randomized into three parallel groups. One group will receive usual care by the general practitioner or sports physician alone, one group will be referred to a podiatrist and will receive a custom made insole, and one group will be referred to a podiatrist and will receive a placebo insole. The primary outcome will be the change from baseline to 12 weeks follow-up in pain severity at rest and during activity on a 0–10 numerical rating scale (NRS). Secondary outcomes include foot function (according to the Foot Function Index) at 6, 12 and 26 weeks, recovery (7-point Likert) at 6, 12 and 26 weeks, pain at rest and during activity (NRS) at 6 and 26 weeks and cost-effectiveness of the intervention at 26-weeks. Measurements will take place at baseline and at, 2, 4, 6, 12 and 26 weeks of follow-up.DiscussionThe treatment of plantar fasciopathy is a challenge for health care professionals. Orthotic devices are frequently applied, despite a lack of evidence of the effectiveness on patient reported outcome. The results of this randomized controlled trial will improve the evidence base for treating this troublesome condition in daily practice.Trial registrationDutch Trial Registration:NTR5346. Date of registration: August 5th 2015.

【 授权许可】

CC BY   
© Rasenberg et al. 2016